Recommendations for wider adoption of clinical pharmacy in Central and Eastern Europe in order to optimise pharmacotherapy and improve patient outcomes

Kamila Urbańczyk, Sonja Guntschnig, Vasilis Antoniadis, Slaven Falamic, Tijana Kovacevic, Marta Kurczewska-Michalak, Branislava Miljković, Anna Olearova, Inese Sviestina, Attila Szucs, Konstantin Tachkov, Zita Tiszai, Daisy Volmer, Anna Wiela-Hojeńska, Daniela Fialova, Jiri Vlcek, Matej Stuhec, Anita Hogg, Michael Scott, Derek StewartAlpana Mair, Silvia Ravera, François-Xavier Lery, Przemysław Kardas

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)
48 Downloads (Pure)

Abstract

Clinical pharmacy as an area of practice, education and research started developing around the 1960s when pharmacists across the globe gradually identified the need to focus more on ensuring the appropriate use of medicines to improve patient outcomes rather than being engaged in manufacturing and supply. Since that time numerous studies have shown the positive impact of clinical pharmacy services (CPS). The need for wider adoption of CPS worldwide becomes urgent, as the global population ages, and the prevalence of polypharmacy as well as shortage of healthcare professionals is rising. At the same time, there is great pressure to provide both high-quality and cost-effective health services. All these challenges urgently require the adoption of a new paradigm of healthcare system architecture. One of the most appropriate answers to these challenges is to increase the utilization of the potential of highly educated and skilled professionals widely available in these countries, i.e., pharmacists, who are well positioned to prevent and manage drug-related problems together with ensuring safe and effective use of medications with further care relating to medication adherence. Unfortunately, CPS are still underdeveloped and underutilized in some parts of Europe, namely, in most of the Central and Eastern European (CEE) countries. This paper reviews current situation of CPS development in CEE countries and the prospects for the future of CPS in that region.
Original languageEnglish
Article number1244151
Pages (from-to)1-16
Number of pages17
JournalFrontiers in Pharmacology
Volume14
Early online date2 Aug 2023
DOIs
Publication statusPublished online - 2 Aug 2023

Bibliographical note

Funding Information:
We would like to acknowledge the input of other representatives from different countries who helped in gathering the data and were not directly involved in manuscript preparation.

Publisher Copyright:
Copyright © 2023 Urbańczyk, Guntschnig, Antoniadis, Falamic, Kovacevic, Kurczewska-Michalak, Miljković, Olearova, Sviestina, Szucs, Tachkov, Tiszai, Volmer, Wiela-Hojeńska, Fialova, Vlcek, Stuhec, Hogg, Scott, Stewart, Mair, Ravera, Lery and Kardas.

Keywords

  • clinical pharmacy
  • cost-effective treatment
  • health policy
  • medication adherence
  • drug safety
  • medication errors
  • drug utilization
  • polypharmacy

Fingerprint

Dive into the research topics of 'Recommendations for wider adoption of clinical pharmacy in Central and Eastern Europe in order to optimise pharmacotherapy and improve patient outcomes'. Together they form a unique fingerprint.

Cite this